We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 4th:
America's Car-Mart, Inc. (CRMT - Free Report) : This automotive retailer has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.1% over the last 60 days.
Taro Pharmaceutical Industries Ltd. : This pharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.7% over the last 60 days.
Taro Pharmaceutical Industries Ltd. Price and Consensus
DLH Holdings Corp. (DLHC - Free Report) : This healthcare and social services provider has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 14.3% over the last 60 days.
Halozyme Therapeutics, Inc. (HALO - Free Report) : This biotechnology company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.
In addition to the stocks discussed above, wouldn't you like to know about our 10 finest buy-and-holds for the year?
From more than 4,000 companies covered by the Zacks Rank, these 10 were picked by a process that consistently beats the market. Even during 2018 while the market dropped -5.2%, our Top 10s were up well into double-digits. And during bullish 2012 – 2017, they soared far above the market's +126.3%, reaching +181.9%.
This year, the portfolio features a player that thrives on volatility, an AI comer, and a dynamic tech company that helps doctors deliver better patient outcomes at lower costs.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for March 4th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 4th:
America's Car-Mart, Inc. (CRMT - Free Report) : This automotive retailer has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.1% over the last 60 days.
America's Car-Mart, Inc. Price and Consensus
America's Car-Mart, Inc. price-consensus-chart | America's Car-Mart, Inc. Quote
America's Car-Mart’s shares gained 18.8% over the last one month against the S&P 500’s rise of 2.9%. The company possesses a Momentum Score of B.
America's Car-Mart, Inc. Price
America's Car-Mart, Inc. price | America's Car-Mart, Inc. Quote
Taro Pharmaceutical Industries Ltd. : This pharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.7% over the last 60 days.
Taro Pharmaceutical Industries Ltd. Price and Consensus
Taro Pharmaceutical Industries Ltd. price-consensus-chart | Taro Pharmaceutical Industries Ltd. Quote
Taro Pharmaceutical’s shares gained 10.1% over the last one month. The company possesses a Momentum Score of A.
Taro Pharmaceutical Industries Ltd. Price
Taro Pharmaceutical Industries Ltd. price | Taro Pharmaceutical Industries Ltd. Quote
DLH Holdings Corp. (DLHC - Free Report) : This healthcare and social services provider has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 14.3% over the last 60 days.
DLH Holdings Corp. Price and Consensus
DLH Holdings Corp. price-consensus-chart | DLH Holdings Corp. Quote
DLH’S shares gained 17.7% over the last one month. The company possesses a Momentum Score of A.
DLH Holdings Corp. Price
DLH Holdings Corp. price | DLH Holdings Corp. Quote
Halozyme Therapeutics, Inc. (HALO - Free Report) : This biotechnology company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.
Halozyme Therapeutics, Inc. Price and Consensus
Halozyme Therapeutics, Inc. price-consensus-chart | Halozyme Therapeutics, Inc. Quote
Halozyme Therapeutics’ shares gained 5.8% over the last one month. The company possesses a Momentum Score of A.
Halozyme Therapeutics, Inc. Price
Halozyme Therapeutics, Inc. price | Halozyme Therapeutics, Inc. Quote
See the full list of top ranked stocks here.
Learn more about the Momentum score and how it is calculated here.
Zacks' Top 10 Stocks for 2019
In addition to the stocks discussed above, wouldn't you like to know about our 10 finest buy-and-holds for the year?
From more than 4,000 companies covered by the Zacks Rank, these 10 were picked by a process that consistently beats the market. Even during 2018 while the market dropped -5.2%, our Top 10s were up well into double-digits. And during bullish 2012 – 2017, they soared far above the market's +126.3%, reaching +181.9%.
This year, the portfolio features a player that thrives on volatility, an AI comer, and a dynamic tech company that helps doctors deliver better patient outcomes at lower costs.
See Stocks Today >>